These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15243351)

  • 1. [Pharmacokinetics and dose adaptation of ofloxacine, pefloxacine and ciprofloxacine during haemodialysis and continuous ambulatory peritoneal dialysis].
    Daniel JP; Moulin B; Christmann D
    Ann Pharm Fr; 2004 May; 62(3):177-85. PubMed ID: 15243351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of quinolones in renal insufficiency.
    Fillastre JP; Leroy A; Moulin B; Dhib M; Borsa-Lebas F; Humbert G
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():51-60. PubMed ID: 2124213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ofloxacin pharmacokinetics in chronic renal failure and dialysis.
    Lameire N; Rosenkranz B; Malerczyk V; Lehr KH; Veys N; Ringoir S
    Clin Pharmacokinet; 1991 Nov; 21(5):357-71. PubMed ID: 1773550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinolone pharmacokinetics and metabolism.
    Lode H; Höffken G; Boeckk M; Deppermann N; Borner K; Koeppe P
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():41-9. PubMed ID: 2124212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of fluoroquinolones in hepatic failure.
    Montay G; Gaillot J
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():61-7. PubMed ID: 2258353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of ofloxacin in healthy subjects and patients with varying degrees of renal impairment.
    Flor S; Guay D; Opsahl J; Tack K; Matzke G
    Int J Clin Pharmacol Res; 1991; 11(3):115-21. PubMed ID: 1809697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfer of ciprofloxacin, ofloxacin and levofloxacin across the perfused human placenta in vitro.
    Polachek H; Holcberg G; Sapir G; Tsadkin-Tamir M; Polachek J; Katz M; Ben-Zvi Z
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):61-5. PubMed ID: 16154040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CAPD peritonitis and fluoroquinolones: a review.
    Janknegt R
    Perit Dial Int; 1991; 11(1):48, 53-8. PubMed ID: 2049423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is the switch of fluoroquinolones from intravenous to oral administration useful in an intensive care unit? Economical approach].
    Turc J; Eve O; Tran Van D; Wey PF; Martinez JY
    Ann Fr Anesth Reanim; 2009 Feb; 28(2):179-80. PubMed ID: 19171451
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of experimental bacterial keratitis with topical trovafloxacin.
    Barequet IS; Denton P; Osterhout GJ; Tuli S; O'Brien TP
    Arch Ophthalmol; 2004 Jan; 122(1):65-9. PubMed ID: 14718297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The case for oral treatment of peritonitis in continuous ambulatory peritoneal dialysis.
    Passadakis P; Oreopoulos D
    Adv Perit Dial; 2001; 17():180-90. PubMed ID: 11510271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and metabolism of intravenous and oral fleroxacin in subjects with normal and impaired renal function and in patients on continuous ambulatory peritoneal dialysis.
    Stuck AE; Frey FJ; Heizmann P; Brandt R; Weidekamm E
    Antimicrob Agents Chemother; 1989 Mar; 33(3):373-81. PubMed ID: 2499248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics of ofloxacin, desmethyl ofloxacin and ofloxacin N-oxide in haemodialysis patients with end-stage renal failure.
    White LO; MacGowan AP; Mackay IG; Reeves DS
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():65-72. PubMed ID: 3182464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of moxifloxacin, ciprofloxacin, gatifloxacin, ofloxacin, and levofloxacin concentrations in human conjunctival tissue.
    Wagner RS; Abelson MB; Shapiro A; Torkildsen G
    Arch Ophthalmol; 2005 Sep; 123(9):1282-3. PubMed ID: 16157821
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of dose on the distribution kinetics of ciprofloxacin and ofloxacin in the isolated hindlimb of the rat.
    Casquero-Dorado AC; Colino CI; Martínez MS; Sánchez-Navarro A
    Biopharm Drug Dispos; 2000 Nov; 21(8):313-9. PubMed ID: 11514950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of ofloxacin and ciprofloxacin erythrocyte distribution.
    Colino CI; García Turiño A; Sanchez Navarro A; Lanao JM
    Biopharm Drug Dispos; 1998 Mar; 19(2):71-7. PubMed ID: 9580344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the penetration of fluoroquinolones in human conjunctival tissue.
    Fiscella RG; Jensen MK
    Arch Ophthalmol; 2006 Dec; 124(12):1796-7; author reply 1797. PubMed ID: 17159052
    [No Abstract]   [Full Text] [Related]  

  • 18. Absorption of topically administered ciprofloxacin, ofloxacin and gentamicin in the inflamed rabbit eye.
    Behrens-Baumann W
    Ophthalmologica; 1996; 210(2):119-22. PubMed ID: 8859488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics of fluoroquinolones].
    Iakovlev VP
    Antibiot Khimioter; 1993 Jun; 38(6):66-78. PubMed ID: 8166571
    [No Abstract]   [Full Text] [Related]  

  • 20. [Excretion of fluoroquinolones into saliva].
    Kelentey BA; Kelentey BJ; Fekete I; Kozma J
    Fogorv Sz; 1995 Sep; 88(9):293-7. PubMed ID: 8522025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.